טוען...
Screening of cytoprotectors against methotrexate-induced cytogenotoxicity from bioactive phytochemicals
As a well known anti-neoplastic drug, the cytogenotoxicity of methotrexate (MTX) has received more attention in recent years. To develop a new cytoprotector to reduce the risk of second cancers caused by methotrexate, an umu test combined with a micronucleus assay was employed to estimate the cytopr...
שמור ב:
| הוצא לאור ב: | PeerJ |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
PeerJ Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4867711/ https://ncbi.nlm.nih.gov/pubmed/27190706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.1983 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|